Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

DGX

Quest Diagnostics (DGX)

Quest Diagnostics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:DGX
FechaHoraFuenteTítuloSímboloCompañía
21/05/202415:29Edgar (US Regulatory)Form 8-K - Current reportNYSE:DGXQuest Diagnostics Inc
20/05/202418:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
20/05/202418:11Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
16/05/202415:15PR Newswire (US)Quest Diagnostics Elects Robert B. Carter, CIO of FedEx Corporation, to Board of DirectorsNYSE:DGXQuest Diagnostics Inc
15/05/202416:45PR Newswire (US)Quest Diagnostics Declares Quarterly Cash DividendNYSE:DGXQuest Diagnostics Inc
15/05/202407:43PR Newswire (US)Workforce Drug Test Cheating Surged in 2023, Finds Quest Diagnostics Drug Testing Index Analysis of Nearly 10 Million Drug TestsNYSE:DGXQuest Diagnostics Inc
07/05/202415:50PR Newswire (US)Quest Diagnostics to Speak at the 2024 Leerink Partners Healthcare Crossroads ConferenceNYSE:DGXQuest Diagnostics Inc
06/05/202408:40PR Newswire (US)Quest Diagnostics Names Murali Balakumar Senior Vice President and Chief Information and Digital OfficerNYSE:DGXQuest Diagnostics Inc
01/05/202405:57PR Newswire (US)Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAINYSE:DGXQuest Diagnostics Inc
23/04/202405:45PR Newswire (US)Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024NYSE:DGXQuest Diagnostics Inc
22/04/202406:53PR Newswire (US)Quest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's DiseaseNYSE:DGXQuest Diagnostics Inc
02/04/202406:57PR Newswire (US)Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental DelayNYSE:DGXQuest Diagnostics Inc
26/03/202406:09PR Newswire (US)Study in Frontiers in Neurology Affirms Amyloid Blood Test Can Help Identify Patients Who May Forgo Imaging Evaluation for Alzheimer's DiseaseNYSE:DGXQuest Diagnostics Inc
19/03/202414:06PR Newswire (US)Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024NYSE:DGXQuest Diagnostics Inc
29/02/202412:50Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DGXQuest Diagnostics Inc
23/02/202408:35PR Newswire (US)Quest Diagnostics to Speak at the Barclays 26th Annual Global Healthcare ConferenceNYSE:DGXQuest Diagnostics Inc
21/02/202406:58PR Newswire (US)Quest Diagnostics and Instacart Collaborate to Reduce Food Insecurity Across the United States with Integrated Patient Health Coaching and Nutritious Grocery DeliveryNYSE:DGXQuest Diagnostics Inc
15/02/202405:00PR Newswire (US)Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer DetectionNYSE:DGXQuest Diagnostics Inc
13/02/202407:07PR Newswire (US)Quest Diagnostics Debuts MelaNodal Predict™ Test, Personalizing Melanoma Risk Prediction to Help Patients Forgo Invasive SurgeryNYSE:DGXQuest Diagnostics Inc
12/02/202407:01PR Newswire (US)First PFAS "Forever Chemicals" Consumer-Initiated Blood Test with Physician Consult Launches on questhealth.comNYSE:DGXQuest Diagnostics Inc
01/02/202405:45PR Newswire (US)Quest Diagnostics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Guidance for Full Year 2024; Increases Quarterly Dividend 5.6% to $0.75 Per ShareNYSE:DGXQuest Diagnostics Inc
31/01/202413:50PR Newswire (US)Ten Years Running: FORTUNE Names Quest Diagnostics one of 2024 "World's Most Admired Companies"NYSE:DGXQuest Diagnostics Inc
24/01/202416:23Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:DGXQuest Diagnostics Inc
22/01/202407:07PR Newswire (US)Haystack Oncology, developer of Haystack MRD™, and TriSalus Life Sciences collaborate in connection with the clinical development of TriSalus' TLR9 agonist in hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and pancreatic adenocarcinomaNYSE:DGXQuest Diagnostics Inc
19/01/202416:12Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
17/01/202408:35PR Newswire (US)Quest Diagnostics to Release Fourth Quarter and Full Year 2023 Financial Results on February 1, 2024NYSE:DGXQuest Diagnostics Inc
17/01/202407:58PR Newswire (US)Fitbit and Quest Diagnostics Collaborate to Advance Research on the Use of Wearable Devices to Improve Metabolic HealthNYSE:DGXQuest Diagnostics Inc
09/01/202407:05Business WireQuest Diagnostics and Ultima Collaborate to Scale Ultima’s Technology in Fast-Growing Minimal Residual Disease and Whole Genome SequencingNYSE:DGXQuest Diagnostics Inc
08/01/202407:56PR Newswire (US)Quest Diagnostics Acquires Select Assets of Outreach Lab Services Business of Steward Health Care SystemNYSE:DGXQuest Diagnostics Inc
08/01/202406:07PR Newswire (US)Haystack Oncology and Alliance Foundation Trials collaborate to use Haystack MRD™ technology in phase II clinical trial for unresectable stage III NSCLCNYSE:DGXQuest Diagnostics Inc
 Showing the most relevant articles for your search:NYSE:DGX

Su Consulta Reciente

Delayed Upgrade Clock